Dayan Cao

552 total citations
18 papers, 319 citations indexed

About

Dayan Cao is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Dayan Cao has authored 18 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Dayan Cao's work include Hepatitis B Virus Studies (4 papers), Cardiac Fibrosis and Remodeling (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Dayan Cao is often cited by papers focused on Hepatitis B Virus Studies (4 papers), Cardiac Fibrosis and Remodeling (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Dayan Cao collaborates with scholars based in China, United States and Croatia. Dayan Cao's co-authors include Yongwen Chen, Huan Xu, Zhihua Ruan, Fei Lei, Xiaohui Li, Yuzhang Wu, Guoning Guo, Chengying Yang, Sheng Guo and Bing Ni and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Gut.

In The Last Decade

Dayan Cao

17 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dayan Cao China 11 120 118 74 47 37 18 319
Yuichiro Yamamoto Japan 10 135 1.1× 46 0.4× 58 0.8× 73 1.6× 24 0.6× 29 356
Theresa H. Wirtz Germany 11 92 0.8× 90 0.8× 120 1.6× 46 1.0× 71 1.9× 41 352
Jawaher Alsughayyir Saudi Arabia 13 117 1.0× 134 1.1× 48 0.6× 57 1.2× 15 0.4× 47 454
Chenxuan Yang China 9 248 2.1× 184 1.6× 105 1.4× 38 0.8× 40 1.1× 21 496
Atta Nawabi United States 8 128 1.1× 38 0.3× 83 1.1× 26 0.6× 39 1.1× 20 312
Milica Stefanović Spain 9 146 1.2× 147 1.2× 121 1.6× 78 1.7× 96 2.6× 26 454
Lin Guan China 12 106 0.9× 48 0.4× 71 1.0× 46 1.0× 24 0.6× 24 307
Arthur M. Magun United States 9 123 1.0× 79 0.7× 60 0.8× 99 2.1× 42 1.1× 14 391
Kenji Bannai Japan 7 122 1.0× 78 0.7× 27 0.4× 110 2.3× 38 1.0× 12 378

Countries citing papers authored by Dayan Cao

Since Specialization
Citations

This map shows the geographic impact of Dayan Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayan Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayan Cao more than expected).

Fields of papers citing papers by Dayan Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dayan Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayan Cao. The network helps show where Dayan Cao may publish in the future.

Co-authorship network of co-authors of Dayan Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Dayan Cao. A scholar is included among the top collaborators of Dayan Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dayan Cao. Dayan Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liu, Boshi, Laiping Zhang, Xiao Guan, et al.. (2025). Interpenetrating network hydrogel-loaded embryonic stem cell-derived endocardial cells improves cardiac function after myocardial infarction. Journal of Translational Medicine. 23(1). 603–603.
2.
Liu, Jie, Xin Chen, Lijun Zeng, et al.. (2024). Targeting S100A9 Prevents β-Adrenergic Activation–Induced Cardiac Injury. Inflammation. 47(2). 789–806. 6 indexed citations
3.
Zhong, Bin, Qiao Liu, Xin Chen, et al.. (2022). Phillyrin attenuates norepinephrine-induced cardiac hypertrophy and inflammatory response by suppressing p38/ERK1/2 MAPK and AKT/NF-kappaB pathways. European Journal of Pharmacology. 927. 175022–175022. 28 indexed citations
4.
Chen, Xinyun, Dayan Cao, Deyong Xiao, et al.. (2021). The Emerging Roles of the RNA Binding Protein QKI in Cardiovascular Development and Function. Frontiers in Cell and Developmental Biology. 9. 668659–668659. 14 indexed citations
5.
Chen, Xin, Jie Liu, Wenjia Wang, et al.. (2020). α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice. Acta Pharmacologica Sinica. 41(11). 1416–1426. 2 indexed citations
6.
Qu, Xiuxia, Ying Liu, Dayan Cao, et al.. (2019). BMP10 preserves cardiac function through its dual activation of SMAD-mediated and STAT3-mediated pathways. Journal of Biological Chemistry. 294(52). 19877–19888. 37 indexed citations
7.
Cao, Dayan, Shuhui Li, Wenjing Lai, et al.. (2019). TLR2-Deficiency Promotes Prenatal LPS Exposure-Induced Offspring Hyperlipidemia. Frontiers in Physiology. 10. 1102–1102. 8 indexed citations
8.
Cao, Dayan, Qin Zhu, Oscar H. Franco, et al.. (2019). [Consensus on fertility preservation treatment for early stage endometrial cancer and atypical hyperplasia].. PubMed. 54(2). 80–86. 2 indexed citations
9.
Guo, Guoning, Hong Li, Dayan Cao, & Yongwen Chen. (2014). The development of endometrial hyperplasia in aged PD-1-deficient female mice. Diagnostic Pathology. 9(1). 97–97. 4 indexed citations
10.
Cao, Dayan, et al.. (2014). Lipopolysaccharide Exposure during Pregnancy Leads to Aortic Dysfunction in Offspring Rats. PLoS ONE. 9(7). e102273–e102273. 13 indexed citations
11.
Guo, Sheng, Yongwen Chen, Dayan Cao, et al.. (2014). VSIG4 expression on macrophages facilitates lung cancer development. Laboratory Investigation. 94(7). 706–715. 71 indexed citations
12.
Xu, Huan, Hong Li, Dayan Cao, Yuzhang Wu, & Yongwen Chen. (2013). Tumor necrosis factor α (TNF-α) receptor-I is required for TNF-α-mediated fulminant virus hepatitis caused by murine hepatitis virus strain-3 infection. Immunology Letters. 158(1-2). 25–32. 11 indexed citations
13.
Liu, Ya, Fei Hao, Haigang Zhang, et al.. (2013). Panax NotoginsengSaponins Promote Endothelial Progenitor Cell Mobilization and Attenuate Atherosclerotic Lesions in Apolipoprotein E Knockout Mice. Cellular Physiology and Biochemistry. 32(4). 814–826. 24 indexed citations
14.
Yang, Chengying, Yongwen Chen, Guoning Guo, et al.. (2012). Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3. Gut. 62(8). 1204–1213. 31 indexed citations
15.
Guo, Guoning, Dayan Cao, Huan Xu, et al.. (2012). The characteristic expression of B7‐H3 and B7‐H4 in liver biopsies from patients with HBV‐related acute‐on‐chronic liver failure. Pathology International. 62(10). 665–674. 8 indexed citations
16.
Xu, Huan, Dayan Cao, Guoning Guo, et al.. (2012). The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure. Diagnostic Pathology. 7(1). 142–142. 18 indexed citations
17.
Li, Jingwei, Dayan Cao, Guoning Guo, Yuzhang Wu, & Yongwen Chen. (2012). Expression and anatomical distribution of TIM-containing molecules in Langerhans cell sarcoma. Journal of Molecular Histology. 44(2). 213–220. 13 indexed citations
18.
Cao, Dayan, Huan Xu, Guoning Guo, et al.. (2012). Intrahepatic Expression of Programmed Death-1 and its Ligands in Patients with HBV-Related Acute-on-Chronic Liver Failure. Inflammation. 36(1). 110–120. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026